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I
t has been estimated that almost 70% of newly generated immature B cells are self-reactive (1) . B cell central tolerance is a process through which self-reactive B cells are rendered nonself-reactive (2) . Central tolerance consists of receptor editing, anergy induction, and clonal deletion. In the bone marrow, selfreactive B cells are initially removed from the repertoires through receptor editing and deletion (3) . The self-reactive B cells that somehow escape deletion in the bone marrow are functionally inactivated by anergy in the periphery. Anergy refers to a persistent state of unresponsiveness to Ag stimulation, and anergic B cells are arrested in their development at the transitional stage (2) . The majority of self-reactive B cells are inactivated by anergy, and breach in B cell anergy has been linked to development of autoimmune diseases (2) .
Three groups of proteins are critical for B cell anergy induction. The first group is the molecules involved in BCR signaling. It has been shown that chronic Ag stimulation leads to monophosphorylation of Iga/b, resulting in biased activation of phosphatase SHIP-1 and adaptor Dok-1 (4) . In anergic B cells, SHIP-1 and Dok-1 are constitutively phosphorylated, leading to activation of an inhibitory circuit that is critical for B cell anergy induction. SHIP-1 deficiency in B cells is alone sufficient to cause lupus-like autoimmune disease in mice (4) . In addition to SHIP-1, signaling molecules, such as Cbl, PKCd, and PTEN, are also critical for establishment of B cell anergy (5) (6) (7) .
The second group is the molecules that promote the survival and differentiation of B cells. BAFF is a cytokine that is critical for survival and differentiation of B2 cells (8) . Anergic B cells have a shorter lifespan, primarily because of their high dependence on BAFF for survival compared with their normal counterparts (9) . The reliance on BAFF for survival and differentiation helps to reinforce B cell anergy, because anergic B cells fail to compete with normal B cells for limited amounts of BAFF. However, when BAFF is overexpressed anergic B cells survive and mature, eventually leading to breakdown of anergy (10) . Bim is a proapoptotic Bcl-2-related protein, and Bim deficiency by itself is sufficient to breach B cell anergy (11) . It has been shown that Bim deficient anergic B cells are able to survive and mature because they are no longer dependent on BAFF for survival (11) .
The third group is transcription factors that mediate B cell responses to Ag stimulation. Transcription factors integrate the signals from BCR and its costimulatory receptors, and in doing so they dictate B cell responses to Ag via regulation of genes that control B cell survival and activation. NFAT1 is one such transcription factor that functions in a calcium-dependent manner, and lack of NFAT1 is sufficient to break B cell anergy (12) . NFAT1-deficient B cells are hyperresponsive to Ag stimulation, indicating that NFAT1 is a negative regulator of Ag responses in B cells (13, 14) . Similarly, c-Myc is rapidly induced upon Ag engagement and is critical for Ag-induced B cell expansion (15) . However, anergic B cells produce low levels of c-Myc and fail to enter the cell cycle upon Ag stimulation (16) . Interestingly, overexpression of c-Myc in anergic B cells can restore B cell responses to Ag stimulation and, by itself, is sufficient to breach B cell anergy (17) . Although defective distal BCR signaling in anergic B cells renders them unresponsive to Ag stimulation, elevated expression of key transcription factors in the anergic B cells, such as c-Myc, could lower their activation threshold, thereby restoring the response of anergic B cells to Ag stimulation.
IRF8, also known as ICSBP, is a critical transcriptional regulator that controls the development and differentiation of multiple lineages of immune cells, including macrophages, dendritic cells, B cells, and T cells (18) . It was demonstrated that IRF8 is required for macrophage development and, in its absence, the granulocyte population is dramatically increased (19) . IRF8 was also shown to induce the expression of PU.1 and EBF1 in hematopoietic progenitor cells to directly promote B cell commitment and specification (20) . Our previous studies showed that IRF8, together with its closely related family member IRF4, orchestrates the transition from large pre-B to small pre-B cells (21) (22) (23) . Additionally, IRF8 was shown to induce Bcl-6 in germinal center reactions (24) . A recent study showed that marginal zone (MZ) B cells and B1 B cells are significantly increased in IRF8-deficient mice. The defects were observed in IRF8 germline mutant (IRF8 2/2 ) mice, as well as conditional-mutant mice, indicating that the defects are B cell intrinsic. Moreover, it was shown that spleens of IRF8 conditional-mutant mice contain twice as many mature B cells as do their counterparts in wild-type mice (25) . MZ and B1 B cells are known to harbor B cells with self-reactive BCRs, and expansion of MZ and B1 B cells is often observed in mice with defects in B cell tolerance induction (26) . In this report, we show that IRF8-deficient mice, both germline and conditional knockout, produced anti-dsDNA Abs. Using a well-established mouse model of B cell anergy, we further demonstrate that B cell anergy was breached in IRF8-deficient mice. Thus, our findings identify IRF8 as a novel regulator of B cell anergy.
Materials and Methods

Mice
IRF8
2/2 mice and conditional-mutant mice were described previously (25, 27) . The BCR-transgenic mice recognizing hen egg lysozyme (HEL-Tg mice; MD4), as well as the transgenic mice expressing secreted hen egg lysozyme (HEL) were obtained from The Jackson Laboratory. IRF8 conditional-mutant mice were bred with CD19Cre mice to generate IRF8 conditional-mutant mice that are hemizygous for CD19Cre (IRF8 fl/fl ). All mice were on the C57BL/6 genetic background and were maintained under specific pathogen-free conditions. Experiments were performed according to guidelines from the National Institutes of Health and with an approved protocol from the Institutional Animal Care and Use Committee of University of Nebraska Medical Center. Mice aged 6-30 wk were used for this study.
ELISA
Anti-HEL ELISA was performed using a previously described method (28) . Sera (1:200 dilutions) were added to a 96-well plate precoated with HEL Ag (10 mg/ml). After washing, the plate was incubated with biotinylated anti-IgMa Ab. The bound Ig was visualized by addition of alkaline phosphatase and para-nitrophenyl phosphate. The raw ODs were converted to U/ml using a control serum from HEL-Tg mice to allow interplate comparison. Anti-dsDNA IgM and IgG ELISA were conducted with kits from Alpha Diagnostic (San Antonio, TX), according to the manufacturer's recommendation.
Cell-proliferation assay with CFSE tracking dye B cells were isolated from mice spleen through negative selection. Briefly, splenocytes were incubated with a mixture of biotinylated Abs against CD3, CD4, CD8, Gr-1, Ter119, and Dx5. After incubation with streptavidinconjugated MicroBeads (Miltenyi Biotec), B cells were isolated with a negative-selection column. The isolated cells were incubated with 1 mM CFSE tracking dye (Molecular Probes) in PBS at 37˚C for 10 min. The stained cells were plated in a 96-well plate in triplicate at 5 3 10 5 cells/ well. The cells were stimulated with different mitogens, including HEL, LPS, and IgM, and analyzed by FACS after 4 d.
Survival assay
The isolated B cells were plated into each well of a 96-well plate in triplicate; incubated with different concentrations of BAFF, HEL, or both; and analyzed at different time points. To distinguish dead and live cells, the treated cells were incubated with propidium iodide (PI) prior to FACS analysis.
FACS analysis
Cells were isolated from mice, preincubated with either 2% rat serum or Fc-Block (2.4G2), and stained with optimal amounts of specific Abs, either biotinylated or directly fluorochrome conjugated. The Abs against B220, IgM, CD93 (AA4.1), CD21, and IgMb were purchased from BD Pharmingen. The stained cells were analyzed with a FACSCalibur flow cytometer.
Measurement of calcium influx
Splenocytes were isolated from mice and stained with Abs against B220. After washing, the stained cells (5 3 10 6 cells/ml) were incubated with 1 mM Indo-1 AM (Molecular Probes) for 30 min at 37˚C in RPMI 1640 medium containing 3% FBS. The calcium influx of loaded cells was analyzed with an LSR II flow cytometer. The baseline emission of fluorescence ratio (405/525 nm) was collected for 1 min, followed by stimulation by HEL at 100 ng/ml. The fluorescence ratio of 405/525 nm was recorded for another 4 min. The increase in the fluorescence ratio was used to reflect the intensity of calcium mobilization upon BCR activation. The data were analyzed with FlowJo software.
Western blot analysis
Splenic B cells were isolated via negative selection. The negatively selected B cells were stimulated with different concentrations of HEL at 37˚C for the indicated times. The cells were lysed, and proteins were separated by SDS-PAGE. The membranes were probed with indicated Abs, and the signals were revealed with an ECL detection system (Pierce). The Abs against IRF4, IRF8, c-Myc, and cyclin D2 were obtained from Santa Cruz Biotechnology.
Generation of inducible IRF8-transgenic mice in B cells
Previously, we generated an inducible IRF4-transgenic mouse in which the expression of IRF4 can be induced in B cell by doxycycline (Dox) (29) . In this study, we used the same approach and generated an inducible IRF8-transgenic mouse. Briefly, a full-length IRF8 cDNA was inserted into the pTet-Splice vector to generate the transgenic construct (IRF8Tg). Expression of the IRF8 transgene is driven by a minimal CMV promoter linked with a tetracycline response element. Three founder lines were established. To induce transgene expression in B cells, we bred IRF8Tg mice with transgenic mice expressing a reverse tetracycline transactivator (rtTA) (30) . The rtTAtransgenic construct, which coexpresses GFP, was inserted into the ROSA26 locus (ROSA-rtTA). ROSA-rtTA was inactive because of an internal stop codon that can be cleaved by Cre recombinase. We bred ROSA-rtTA mice with CD19-cre mice to generate B cell-specific expression of rtTA (CD19 rtTA). CD19rtTA mice were subsequently mated with IRF8Tg mice to generate mice in which the expression of IRF8 transgene can be induced exclusively in B cells (CD19creIRF8Tg). In this system, the expression of IRF8 transgene is induced only in the presence of Dox. The founder line expressing the highest level of IRF8 transgene was chosen for subsequent studies. Eight-to twelve-week-old mice were used for this study.
TUNEL assay
The apoptosis status of splenic B cells in mice was examined with a TUNEL assay. The TUNEL assay was conducted as we described previously (31, 32) . CD19creIRF8Tg and CD19cre mice were administered Dox water for 4 wk. Splenic B cells were isolated from the mice and stained with surface Abs against CD93, B220, and IgM. TUNEL + cells were revealed with an APO-direct kit (BD Pharmingen).
Results
IRF8-deficient mice, both germline and B cell specific, produce anti-dsDNA Abs
To determine whether deficiency in IRF8 leads to breakdown of B cell tolerance, we measured titers of serum anti-dsDNA Abs. As shown in Fig 1A, IRF8 2/2 mice produced higher titers of antidsDNA IgM and IgG Abs than did IRF8 +/+ mice. Importantly, the titers of anti-dsDNA IgM and IgG were also found to be higher in IRF8 fl/fl mice than in IRF8 heterozygous mutant mice (IRF8 fl/+ ) (Fig. 1B) . Anti-dsDNA Abs can be detected in IRF8 2/2 mice at 3 mo of age. In contrast, the anti-dsDNA Abs can only be detected in IRF8 fl/fl mice $5 mo of age. Together, our results show that IRF8-deficient B cells produce anti-dsDNA Abs, indicating that IRF8 plays a role in B cell-tolerance induction.
B cell anergy is breached in IRF8-deficient mice
The majority of self-reactive B cells are removed via anergy induction in the periphery. However, the role of IRF8 in B cell anergy
The Journal of Immunologyinduction is unclear. The most widely used mouse model of B cell anergy is a double-transgenic mouse that consists of a transgenic BCR recognizing HEL and a second transgene expressing secreted HEL (33) . B cells in HEL-Tg mice expressing secreted HEL Ag (sHEL-Tg) are anergic and are unable to produce anti-HEL Abs. To determine the role of IRF8 in B cell anergy induction, we bred IRF8 2/2 mice with sHEL-Tg mice to generate sHEL-Tg mice deficient for IRF8 (IRF8 2/2 sHEL-Tg). Blood was collected from mice, and ELISA was performed to measure titers of anti-HEL Ab. As shown in Fig. 2A matured beyond the transitional stage. One of the key features of anergic B cells is the reduced level of surface IgM. Indeed, the expression level of IgM is much lower in IRF8 +/+ sHEL-Tg mice than in IRF8 +/+ HEL-Tg mice (Fig. 3B) . However, B cells in IRF8 2/2 sHEL-Tg mice expressed a higher level of surface IgM than did the anergic B cells in IRF8 +/+ sHEL-Tg mice. It was shown that anergic B cells in sHEL-Tg mice express low levels of CD21, and upregulation of CD21 expression has been linked to a breach in B cell anergy (11) . Consistent with this previous report, CD21 was expressed at a low level in the anergic B cells of IRF8 +/+ sHEL-Tg mice (Fig. 3B) 2/2 HEL-Tg mice (Fig. 4A, upper panel) . The amplitudes of calcium influx triggered by BCR signaling were comparable between IRF8 counterparts in IRF8 +/+ HEL-Tg mice (Fig. 6A) . At a low HEL concentration (20 ng/ml), CFSE dilution was observed only in B cells isolated from IRF8 2/2 HEL-Tg mice. Surprisingly, B cell proliferation induced by anti-IgM cross-linking and LPS was comparable between B cells isolated from IRF8 +/+ HEL-Tg and IRF8
2/2 HEL-Tg mice (Supplemental Fig. 1 ). These results indicate that B cells in IRF8 2/2 HEL-Tg mice are hyperproliferative only to stimulation by the cognate Ag. We further examined the induction of c-Myc, cyclin D2, and IRF4 by HEL (Fig. 6B) . Our results show that their induction in B cells isolated from IRF8 (Fig. 7D) . Finally, Ag-induced cell proliferation was also found to be more pronounced in B cells isolated from IRF8 fl/fl HEL-Tg mice than in B cells from IRF8 fl/+ HEL-Tg control mice (Fig. 7E) . Together, our results indicate that IRF8 IRF8 is expressed at high levels in anergic B cells, and induction of IRF8 transgene triggers apoptosis in transitional B cells IRF8 is expressed throughout B cell development; however, its expression level in anergic B cells is unclear. We measured the expression level of IRF8 in B cells isolated from IRF8 +/+ HEL-Tg mice and IRF8 +/+ sHEL-Tg mice. Interestingly, IRF8 was expressed at a 2-fold higher level in anergic B cells compared with normal B cells (Fig. 8A ). This result is consistent with our findings that IRF8 is important for anergy induction. We wanted to determine the effect of a high level of IRF8 on B cells. To this end, we generated inducible IRF8-transgenic mice in which the expression of IRF8 can be induced by Dox in B cells. CD19CreIRF8Tg mice and CD19cre control mice were administered Dox for 4 wk, and GFP + splenic B cells were isolated by sorting. Our results show that expression levels of IRF8 were comparable between CD19creIRF8Tg and CD19cre control mice given regular water (Fig. 8B, Untreated) . However, in the presence of Dox water, the expression of IRF8 in B cells was 2.5-fold higher in CD19creIRF8Tg mice than in CD19Cre control mice, indicating that Dox treatment induced the expression of the IRF8 transgene (Fig. 8B, Dox) . To assess the effect of IRF8 transgene expression on B cell development in spleen, the numbers of transitional T1, T2, T3, and mature B cells (CD93 2 ) were counted (Fig. 8C) . Compared with CD19Cre mice, the number of CD93
2 mature B cells was moderately decreased in CD19creIRF8Tg mice. In contrast, the numbers of transitional B cells, particularly T2 and T3, were significantly decreased in CD19creIRF8Tg mice. TUNEL assays further showed that the percentages of apoptotic transitional B cells were significantly increased in CD19creIRF8Tg mice (Fig. 8D) HEL-Tg mice, the HEL-Tg mice become hypersensitive to BAFF, a property that could lead to breach of anergy by promoting survival and maturation of anergic B cells. How IRF8 regulates B cell survival remains to be determined. Previous studies linked the proapoptotic effect of IRF8 to several putative targets, including Bax, Bcl-2, and acid ceramidase (36) (37) (38) sHEL-Tg mice to proliferate and secrete Abs.
Our results indicate that IRF8 functions in a B cell-intrinsic fashion to regulate B cell survival and response to Ag stimulation. IRF8 is critical for the development of several lineages of blood cells, and IRF8 germline-deficient mice exhibit defects in multiple lineages, including T, B, and myeloid cells (39) . Because of this, the B cell defects observed in IRF8 germline-mutant mice could be B cell-extrinsic defects that are caused indirectly by the pleiotropic effects of IRF8. However, our study shows that B cell survival and response to Ag stimulation were similarly affected in the IRF8 conditional-mutant mice, indicating that those defects are B cell specific. Because B cell tolerance can be influenced by defects in other immune cells, such as T cells and myeloid cells, it is possible that abnormalities in other lineage cells also contribute to the tolerance breakdown in IRF8 germline-deficient mice. Our findings that B cells in IRF8 conditional-mutant mice produced lower titers of anti-dsDNA Ab and did so at later time points than did B cells in IRF8 germline-mutant mice are consistent with this scenario.
Two recent genome-wide single-nucleotide polymorphism-association studies identified IRF8 as a major susceptibility gene for systemic lupus erythematosus (SLE) (40, 41) . One of the studies also showed that the single-nucleotide polymorphisms cause a high level of IRF8 in lupus patients (40) . The involvement of IRF8 in SLE was linked to its function in IFN signaling and production (40, 41) . Consistent with this assertion, a recent study demonstrated that lupus development was attenuated in New Zealand Black mice deficient for IRF8 (42) . This study further shows that IRF8-deficient mice are lacking in plasmacytoid dendritic cells, which are the major producers of type 1 IFN in vivo (42) . Together, these studies establish the requirement for IRF8 in lupus development. However, the results from this study show that lack of IRF8 in B cells leads to breakdown of B cell tolerance, which could also contribute to the development of autoimmune diseases. The paradoxical role that IRF8 plays in the development of autoimmune diseases mirrors that of TLRs. It has been well documented that TLR signaling is critical for IFN production and class-switching and is absolutely required for lupus development (43) (44) (45) . However, it also was shown that lack of TLR signaling during B cell development leads to the breakdown of B cell tolerance (46) . Like TLRs, the role of IRF8 in autoimmunity is complex and stage specific. Given the contradicting roles that IRF8 plays in SLE, our findings would caution against using IRF8 as a therapeutic target for lupus.
